関連する実験動画
Updated: Feb 2, 2026

09:09
In Silico Clinical Trials for Cardiovascular Disease
Published on: May 27, 2022
2.3K
遺伝性血管腫発作の予防におけるラナデルマブとプラセボの効果: ランダム化臨床試験
Aleena Banerji1, Marc A Riedl2, Jonathan A Bernstein3
1Division of Rheumatology, Allergy, and Immunology, Department of Medicine, Massachusetts General Hospital, Harvard Medical School, Boston.
JAMA
|November 28, 2018
まとめ
ラナデルマブは第3相試験で遺伝性血管腫の発作を著しく減少させた. このモノクローナル抗体は,遺伝性血管腫 (HAE) の患者に有望な予防療法を提供する.
科学分野:
- 免疫学
- 薬理学について
背景:
- 遺伝性血管腫 (HAE) の現在の長期予防治療には限界があります.
- HAEは珍しい遺伝疾患で 繰り返し発症する腫れが特徴です
研究 の 目的:
- 血カルリクレインを標的とするモノクローナル抗体であるラナデルマブのHAE発症を予防する効果を評価する.
- HAEの予防療法としてのラナデルマブの安全性と耐性を評価する.
主な方法:
- 第3相,ランダム化,ダブルブラインド,プラセボ対照試験で,HAEタイプIまたはIIの患者125人が参加しました.
- 患者は26週間の間,皮下投与ラナデルマブ (150 mg 4週間毎,300 mg 4週間毎,または300 mg 2週間毎) またはプラセボを投与された.
主要な成果:
- プラセボと比較して,ラナデルマブはすべての試験療法においてHAEの月間発症率を有意に低下させた (P< .001).
- ラナデルマブ群で最も頻繁に発生した副作用は,注射部位での反応とめまいがみられた.
- 患者の90. 4%が26週間の試験を終えた.
結論:
- HAE発作の頻度を下げるのに有意な効果を示した.
- ラナデルマブは,遺伝性血管腫の患者に対する新たな予防治療の選択肢です.
- 長期的な安全性と有効性のプロファイルを確立するために,さらなる研究が必要である.
関連する概念動画
The Placebo Effect
6.9K
The placebo effect occurs when people's expectations or beliefs influence or determine their experience in a given situation. In other words, simply expecting something to happen can actually make it happen.
6.9K
Clinical Trials
10.5K
Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
There are four phases in a clinical trial. A phase one...
10.5K
Clinical Trials: Overview
4.9K
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
4.9K
Statistical Software for Data Analysis and Clinical Trials
1.5K
Statistical software is pivotal in data analysis and clinical trials by providing tools to analyze data, draw conclusions, and make predictions. These software packages range from simple data management applications to complex analytical platforms, supporting various statistical tests, models, and simulation techniques. Their significance lies in their ability to handle vast amounts of data with precision and efficiency, enabling researchers to validate hypotheses, identify trends, and make...
1.5K
Acid Attack on Concrete
756
When acids come into contact with concrete, they initiate a chemical reaction that dissolves the hydrated cement paste. This process leads to softening and structural weakening of the concrete. This issue is commonly observed in environments such as chimneys, sewers, and industrial settings. The severity of the damage increases as the pH of the water interacting with the concrete drops below 6.5. In particular, a pH under 4.5 can cause significant concrete damage.
The rate at which hydrogen...
The rate at which hydrogen...
756
Sulfate Attack on Concrete
740
Sulfate attack on concrete is a deterioration process characterized by a whitish discoloration beginning at the edges and corners, accompanied by cracking and spalling. This phenomenon occurs when sulfates react with the components of hardened concrete, forming compounds like calcium sulfate and calcium sulfoaluminate which occupy more space than the substances they replace, causing the concrete to expand and disrupt.
Sulfates from sources like soil, groundwater, or industrial effluents...
Sulfates from sources like soil, groundwater, or industrial effluents...
740

